Searched for
ARIHANT CAPITAL
Eligible for 75% EPF balance withdrawal and planning to do so? Think again and find out how much it will cost you to rebuild itNew EPF withdrawal rules offer greater flexibility for salaried employees. Experts caution against withdrawing retirement savings premature...
Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or Skip?Manipal Health Enterprises' large IPO is experiencing cautious investor interest on its second day. The grey market premium remains modest,...
Manipal Health’s Rs 9,275 crore IPO opens for subscription. Should you apply?Manipal Health Enterprises' Rs 9,275-crore IPO opened for subscription on July 29 with a muted grey market premium of around 2%, signalling...
Hybrid SIFs: How these specialised investment funds are filling the risk-return gapHybrid long-short funds rival debt, arbitrage and hybrid funds, but look beyond the label.
Up in the air! Can SBI Funds Management IPO investors look past OFS to expect strong listing day gains?SBI Funds Management's large IPO presents a valuation opportunity for investors. The offer for sale structure may temper immediate listing ...
India's favourite safe haven? Why gold hype is facing a reality check in 2026Gold's appeal as a safe haven has slowed after a strong rally this year. Profit-booking and easing geopolitical tensions have led to a mark...
HNIs turn to hybrid debt funds, SIFs for higher post-tax returnsRich investors are exploring niche mutual funds and specialized investment funds. These products offer higher returns and better tax effici...
Investing for your child's future through PPF? Here's what every parent should know before opening a PPF accountParents can open a Public Provident Fund (PPF) account for their minor children to secure their future, benefiting from compounding over th...
Vedanta, NALCO, Hindustan Zinc shares fall up to 3% as silver, aluminium, other metal prices tumble. Here's whyMetal stocks including Vedanta, NALCO and Hindustan Zinc fell up to 3% as global metal prices declined sharply. A stronger US dollar, easin...
Metal companies' hot run comes to an end as West Asia cools offMetal stocks experienced a significant downturn Tuesday, with the Nifty Metal index dropping 3.2% as falling commodity prices, domestic eco...
Arihant Capital announces launch of Arihant Bharat Advantage Fund, a Category III AIFArihant Capital Markets has launched the Arihant Bharat Advantage Fund, a Category III AIF focused on investing in high-potential companies...
Banker Ajay Jain joins Arihant Capital to lead and scale its investment banking & merchant banking businessA Chartered Accountant with an Executive MBA and an Independent Director certification, Jain has previously served as Chairman & MD at Mona...
Arihant Capital settle case with Sebi; pays over Rs 17 lakh as settlement chargesThe order came after Arihant Capital proposed to settle the instant proceedings initiated against it, "without admitting or denying the fin...
- Buy Infosys for target of Rs 2795-2835: Arihant
Arihant Capital Markets has advised traders to buy Infosys for target of Rs 2795-2835.
- Buy Wipro for target of Rs 450-465:Arihant
Arihant Capital Market has advised traders to buy Wipro for target of Rs 450-465.
- Buy Reliance Infra for target of Rs 1265-1365: Arihant
Arihant Capital Market has advised traders to buy Reliance Infrastructure for target of Rs 1265-1365.
- Buy BHEL for target of Rs 2455: Arihant
Arihant Capital Market has advised traders to buy BHEL for target of Rs 2455.
- Buy Reliance Capital for target of Rs 820-835: Arihant
Arihant Capital Market has advised traders to buy Reliance Capital for target of Rs 820-835.
- Buy Reliance for target of Rs 1135-1180: Arihant
Arihant Capital Market has advised traders to buy Reliance for target of Rs 1135-1180.
- Buy Ranbaxy for target of Rs 458-465: Arihant
Arihant Capital Markets has advised traders to buy Ranbaxy Laboratories for target of Rs 458-465.